{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:37:39Z","timestamp":1787027859437,"version":"build-2736575974"},"reference-count":53,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Chemotherapy-induced peripheral neuropathy (CIPN) impairs quality of life and may result in discontinuation of anti-neoplastic therapy. In older patients, CIPN is associated with reduced executive function, more severe pain, comorbidities and polypharmacy. The use of magnetic fields to modulate central and peripheral neurons may offer some benefit for relieving neuropathic pain, with few adverse effects. The evidence of the benefits of using transcranial magnetic stimulation (TMS) or peripheral magnetic stimulation (PMS) in patients with CIPN is evaluated in this narrative review. Improved patient-reported outcomes and more rapid nerve conduction velocities in preliminary trials suggest efficacy in patients with CIPN. The potential for additional, broader applications in CIPN includes biomarkers of progression to chronic neuropathic pain, opioid-sparing benefits, and mitigating associated depression and anxiety. Because magnetic stimulation (MS) is relatively resource intense and time consuming, requiring multiple sessions of therapy, its availability is still limited, and multi-center trials are challenging. Further research with sham-controlled clinical trials, using standardized MS techniques and outcome assessments are needed.<\/jats:p>","DOI":"10.3390\/cancers17223628","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:13:41Z","timestamp":1762920821000},"page":"3628","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Transcranial Magnetic Stimulation and Peripheral Magnetic Field Therapy in Chemotherapy-Induced Peripheral Neuropathy: A Narrative Review"],"prefix":"10.3390","volume":"17","author":[{"given":"Elena","family":"Wernecke","sequence":"first","affiliation":[{"name":"Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faten","family":"Ragaban","sequence":"additional","affiliation":[{"name":"Division of Palliative Medicine, Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Rosenquist","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Health Behavior,  Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7122-0460","authenticated-orcid":false,"given":"Nikhil","family":"Jaganathan","sequence":"additional","affiliation":[{"name":"Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4515-5041","authenticated-orcid":false,"given":"William J.","family":"Healy","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidio Giacomo","family":"Del Fabbro","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lee, K.T., Bulls, H.W., Hoogland, A.I., James, B.W., Colon-Echevarria, C.B., and Jim, H.S.L. (2024). Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Narrative Review and Proposed Theoretical Model. Cancers, 16.","DOI":"10.3390\/cancers16142571"},{"key":"ref_2","first-page":"e12421","article-title":"Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): A secondary analysis of randomised controlled trial\u2014CALGB\/alliance 170601","volume":"26","author":"Smith","year":"2015","journal-title":"Eur. J. Cancer Care"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Starobova, H., and Vetter, I. (2017). Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. Front. Mol. Neurosci., 10.","DOI":"10.3389\/fnmol.2017.00174"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.6004\/jnccn.2009.0009","article-title":"Impact of Chemotherapy Dose Intensity on Cancer Patient Outcomes","volume":"7","author":"Lyman","year":"2009","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101765","DOI":"10.1016\/j.jgo.2024.101765","article-title":"The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study","volume":"15","author":"McNeish","year":"2024","journal-title":"J. Geriatr. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Pereira, S., Ara\u00fajo, N., Fontes, F., Lopes-Concei\u00e7\u00e3o, L., Dias, T., Ferreira, A., Morais, S., Cruz, V.T., and Lunet, N. (2023). Cancer-Related Neuropathic Pain, Chemotherapy-Induced Peripheral Neuropathy and Cognitive Decline in a 5-Year Prospective Study of Patients with Breast Cancer\u2014NEON-BC. Healthcare, 11.","DOI":"10.3390\/healthcare11243132"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e2036695","DOI":"10.1001\/jamanetworkopen.2020.36695","article-title":"Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy","volume":"4","author":"Mizrahi","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Argyriou, A.A., Velasco, R., Kalofonou, F., Litsardopoulos, P., Alemany, M., Rikos, D., Kalofonos, H.P., and Bruna, J. (2025). Gender and age effects on the incidence and severity of chemotherapy-induced neuropathic pain: A propensity score matching analysis. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-14579-x"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1200\/JCO.2015.66.2346","article-title":"Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials","volume":"34","author":"Hershman","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/0284186X.2021.2007283","article-title":"The prevalence, distribution and impact of peripheral neuropathy among Danish patients with cancer\u2014A population-based cross-sectional study","volume":"61","author":"Nielsen","year":"2021","journal-title":"Acta Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO\u2013EONS\u2013EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.rehab.2015.05.005","article-title":"Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS)","volume":"58","author":"Klomjai","year":"2015","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1111\/ejn.15195","article-title":"Selecting stimulation intensity in repetitive transcranial magnetic stimulation studies: A systematic review between 1991 and 2020","volume":"53","author":"Turi","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Flatscher, J., Lori\u00e8, E.P., Mittermayr, R., Meznik, P., Slezak, P., Redl, H., and Slezak, C. (2023). Pulsed Electromagnetic Fields (PEMF)\u2014Physiological Response and Its Potential in Trauma Treatment. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411239"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pbiomolbio.2024.01.003","article-title":"Promising application of pulsed electromagnetic fields on tissue repair and regeneration","volume":"187","author":"Su","year":"2024","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neucli.2015.08.002","article-title":"Repetitive peripheral magnetic stimulation to reduce pain or improve sensorimotor impairments: A literature review on parameters of application and afferents recruitment","volume":"45","author":"Beaulieu","year":"2015","journal-title":"Neurophysiol. Clin."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neucli.2021.06.003","article-title":"Posterior-superior insular deep transcranial magnetic stimulation alleviates peripheral neuropathic pain\u2014A pilot double-blind, randomized cross-over study","volume":"51","author":"Dongyang","year":"2021","journal-title":"Neurophysiol. Clin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41983-019-0075-x","article-title":"Repetitive TMS in treatment of resistant diabetic neuropathic pain","volume":"55","author":"Abdelkader","year":"2019","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"key":"ref_20","first-page":"E203","article-title":"Short-term Effect of Repetitive Transcranial Magnetic Stimulation on Diabetic Peripheral Neuropathic Pain","volume":"25","author":"Yang","year":"2022","journal-title":"Pain Physician"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Alipour, M., Abdolmaleki, M., Shabanpour, Y., Zali, A., Ashrafi, F., Nohesara, S., and Hajipour-Verdom, B. (2025). Advances in magnetic field approaches for non-invasive targeting neuromodulation. Front. Hum. Neurosci., 19.","DOI":"10.3389\/fnhum.2025.1489940"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ejp.576","article-title":"Repetitive transcranial magnetic stimulation in neuropathic pain secondary to malignancy: A randomized clinical trial","volume":"19","author":"Khedr","year":"2015","journal-title":"Eur. J. Pain"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tang, Y., Chen, H., Zhou, Y., Tan, M.-L., Xiong, S.-L., Li, Y., Ji, X.-H., and Li, Y.-S. (2022). Analgesic Effects of Repetitive Transcranial Magnetic Stimulation in Patients with Advanced Non-Small-Cell Lung Cancer: A Randomized, Sham-Controlled, Pilot Study. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.840855"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"20503121231209088","DOI":"10.1177\/20503121231209088","article-title":"Repetitive transcranial magnetic stimulation for chemotherapy-induced peripheral neuropathy in multiple myeloma: A pilot study","volume":"11","author":"Yan","year":"2023","journal-title":"SAGE Open Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jocn.2020.01.020","article-title":"Pilot study of repetitive transcranial magnetic stimulation in patients with chemotherapy-induced peripheral neuropathy","volume":"73","author":"Goto","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/bem.22005","article-title":"Magnetic field therapy in patients with cytostatics-induced polyneuropathy: A prospective randomized placebo-controlled phase-III study","volume":"38","author":"Rick","year":"2016","journal-title":"Bioelectromagnetics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/bem.21897","article-title":"Low frequency magnetic field therapy in patients with cytostatic-induced polyneuropathy: A phase II pilot study","volume":"36","author":"Geiger","year":"2015","journal-title":"Bioelectromagnetics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1093\/brain\/awab208","article-title":"Repetitive transcranial magnetic stimulation for neuropathic pain: A randomized multicentre sham-controlled trial","volume":"144","author":"Attal","year":"2021","journal-title":"Brain"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/j.pain.0000000000003297","article-title":"Prediction of the response to repetitive transcranial magnetic stimulation of the motor cortex in peripheral neuropathic pain and validation of a new algorithm","volume":"166","author":"Attal","year":"2025","journal-title":"Pain"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.wneu.2024.01.010","article-title":"Optimal Frequency in Repetitive Transcranial Magnetic Stimulation for the Management of Chronic Pain: A Network Meta-Analysis of Randomized Controlled Trials","volume":"184","author":"Naik","year":"2024","journal-title":"World Neurosurg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/cncr.26614","article-title":"Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients","volume":"118","author":"Won","year":"2011","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2217\/pmt.15.19","article-title":"Mechanisms involved in the development of chemotherapy-induced neuropathy","volume":"5","author":"Walters","year":"2015","journal-title":"Pain Manag."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S1470-2045(11)70131-0","article-title":"Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics","volume":"12","author":"Cavaletti","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_34","first-page":"833","article-title":"Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724)","volume":"29","author":"Albany","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Desforges, A.D., Hebert, C.M., Spence, A.L., Reid, B., Dhaibar, H.A., Cruz-Topete, D., Cornett, E.M., Kaye, A.D., Urits, I., and Viswanath, O. (2022). Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update. Biomed. Pharmacother., 147.","DOI":"10.1016\/j.biopha.2022.112671"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/spcare-2022-003815","article-title":"Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): Systematic review and meta-analysis","volume":"13","author":"Chow","year":"2022","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/j.pain.0000000000003484","article-title":"A 5-day course of repetitive transcranial magnetic stimulation before pain onset ameliorates future pain and increases sensorimotor peak alpha frequency","volume":"166","author":"Chowdhury","year":"2024","journal-title":"PAIN\u00ae"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/schbul\/sbae158","article-title":"Safety of rTMS for Schizophrenia: A Systematic Review and Meta-analysis","volume":"51","author":"Blyth","year":"2024","journal-title":"Schizophr. Bull."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clinph.2020.10.003","article-title":"Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines","volume":"132","author":"Rossi","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.clinph.2020.02.008","article-title":"TMS-induced seizure cases stratified by population, stimulation protocol, and stimulation site: A systematic literature search","volume":"131","author":"Chou","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.clinph.2019.03.016","article-title":"Seizures from transcranial magnetic stimulation 2012\u20132016: Results of a survey of active laboratories and clinics","volume":"130","author":"Lerner","year":"2019","journal-title":"Clin. Neurophysiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.brs.2023.02.012","article-title":"European reclassification of non-invasive brain stimulation as class III medical devices: A call to action","volume":"16","author":"Baeken","year":"2023","journal-title":"Brain Stimul."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/j.pain.0000000000003220","article-title":"Characterizing the opioidergic mechanisms of repetitive transcranial magnetic stimulation\u2013induced analgesia: A randomized controlled trial","volume":"165","author":"Liu","year":"2024","journal-title":"PAIN\u00ae"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clinph.2023.02.174","article-title":"Analgesic efficacy of theta-burst stimulation for postoperative pain","volume":"149","author":"Cheng","year":"2023","journal-title":"Clin. Neurophysiol."},{"key":"ref_45","first-page":"211","article-title":"Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis","volume":"28","author":"Friedrich","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4088\/JCP.16cs10905","article-title":"Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression","volume":"79","author":"McClintock","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"26323524221125244","DOI":"10.1177\/26323524221125244","article-title":"Assessment of total pain in people in oncologic palliative care: Integrative literature review","volume":"16","author":"Rezende","year":"2022","journal-title":"Palliat. Care Soc. Pract."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/oncolo\/oyac184","article-title":"Open-Label Placebo for the Treatment of Cancer-Related Fatigue in Patients with Advanced Cancer: A Randomized Controlled Trial","volume":"27","author":"Yennurajalingam","year":"2022","journal-title":"Oncologist"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejca.2009.12.008","article-title":"Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools","volume":"46","author":"Cavaletti","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pbiomolbio.2023.04.001","article-title":"The effect of magnetic fields on tumor occurrence and progression: Recent advances","volume":"179","author":"Zhang","year":"2023","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_51","first-page":"e784","article-title":"Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy","volume":"24","author":"Santos","year":"2018","journal-title":"Oncologist"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ygyno.2018.12.002","article-title":"A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer","volume":"152","author":"Bulls","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/cpt.2314","article-title":"Coprescription of Opioids with Other Medications and Risk of Opioid Overdose","volume":"110","author":"Khan","year":"2021","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/22\/3628\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:15:25Z","timestamp":1762920925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/22\/3628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":53,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["cancers17223628"],"URL":"https:\/\/doi.org\/10.3390\/cancers17223628","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]}}}